Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Ivermectin for Prevention and Treatment of COVID-19 Infectio... : American Journal of
Therapeutics Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic …

Background. Ivermectin has received particular attention as a potential treatment for COVID-
19. However, the evidence to support its clinical efficacy is controversial. Objectives. We …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …

Background: After COVID-19 emerged on US shores, providers began reviewing the
emerging basic science, translational, and clinical data to identify potentially effective …

Background We systematically assessed benefits and harms of the use of ivermectin (IVM)
in patients with coronavirus disease 2019 (COVID-19). Methods Published and preprint …

Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …

Background Ivermectin became a popular choice for COVID-19 treatment among clinicians
and the public following encouraging results from pre-print trials and in vitro studies. Early …

ABSTRACT As COVID-19 (coronavirus disease 2019) continues to rapidly spread
throughout the world, the incidence varies greatly among different countries. These …